Table 1.
Caregiver characteristics | Noncompleters (N=47) | Completers (N=118) | Total (N=165) | Pa |
---|---|---|---|---|
Age, mean±SD b | 61.7±12.7 | 61.4±11.9 | 61.5±12.1 | 0.877 |
Female, % | 87.2 | 90.7 | 89.7 | 0.573 |
White, % | 89.1 | 92.3 | 91.4 | 0.105 |
≤ High school graduate, % | 23.4 | 17.9 | 19.5 | 0.570 |
Not working, % | 72.3 | 72.4 | 72.4 | 0.989 |
Income >$20,000 per year, % | 66.0 | 67.8 | 67.3 | 0.365 |
Live together with CR, %c | 61.7 | 58.5 | 59.4 | 0.743 |
Give personal care to CR daily/almost daily, % | 15.9 | 24.1 | 21.8 | 0.247 |
Time for exercise ≥ 1 hour/week, % | 38.3 | 44.1 | 42.7 | 0.672 |
Time for relaxation techniques or stress management ≥ 1 hour/week, % | 31.9 | 23.7 | 25.8 | 0.452 |
Noncompleters (N=47) | Completers (N=118) | Total (N=165) | P * | |
Health-risk behaviors, mean±SD | 4.0± 2.4 | 3.5± 2.2 | 3.6± 2.2 | 0.147 |
Psychological well-being scale, mean±SD | 8.4± 2.7 | 8.9± 2.6 | 8.8± 2.6 | 0.122 |
Relation to CR, % | ||||
Spouse | 42.6 | 42.3 | 42.4 | |
Offspring | 44.7 | 39.0 | 40.6 | 0.142 |
Offspring-in-law | 6.4 | 2.5 | 3.6 | |
Other | 6.4 | 15.3 | 12.7 | |
Missing | 0.0 | 0.8 | 0.6 | |
Care Recipient Conditions, % d | ||||
Dementia | 42.6 | 52.5 | 49.7 | 0.301 |
Stroke | 14.9 | 21.2 | 19.4 | 0.393 |
Movement disorder | 10.6 | 14.4 | 13.3 | 0.619 |
Diabetes mellitus | 21.3 | 15.3 | 17.0 | 0.364 |
Heart disease | 29.8 | 22.9 | 24.8 | 0.354 |
Cancer | 8.5 | 11.0 | 10.3 | 0.781 |
Other e | 21.3 | 24.6 | 23.6 | 0.691 |
P-value for difference between those who completed posttest and those who did not complete posttest questionnaire.
SD: standard deviation.
CR: care recipient.
Percents do not add to 100 because respondents were asked to select all that applied.
Other category, created from write-in responses, included the following conditions that have implications for physical functioning and therefore, caregiving: Musculoskeletal diseases (e.g., osteoarthritis), eye diseases (e.g., macular degeneration), central nervous system diseases (e.g., multiple sclerosis), depression, psychosis, end-stage renal disease, and chronic lung disease.